Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Harvard Business School
Dow
AstraZeneca
Boehringer Ingelheim

Last Updated: December 8, 2019

DrugPatentWatch Database Preview

Litigation Details for TAKEDA PHARMACEUTICAL CO. LTD. v. DUDAS (D.C. 2006)

See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in TAKEDA PHARMACEUTICAL CO. LTD. v. DUDAS
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for TAKEDA PHARMACEUTICAL CO. LTD. v. DUDAS (D.C. 2006)

Date Filed Document No. Description Snippet Link To Document
2007-04-27 18 Exhibit 20 7: 14 24:8,11 based 13:3 l'l:ll 18:17 26:4 27:19 28:7 basic 5:l'] 12:14 13:2 14:2 ]6:Ii basically…final product patents[ to make 8 it easy. .9 And the starting material patent is the 10 patent that ends …final product patents with the starting material patent. because if you allow double patenting based on multiple…UNITED STATES PATENT AND TRADEMARK OFFICE ‘ JUL '1 In re: Merged 4ZUB - U,s. PATENT AND mADEM…the two patents that relate to the final product 5 that are the basis of the double patenting 6 rejection External link to document
2007-06-29 23 Exhibit 30 4.689.404 t Production o__f cvtosine nucleosides 879 4,689.333 2-(2~pvridv1methvlthio (sultinv1)_)___benzimidazoles…] Searching' US Patent Collecri`on... Results of Search in US Patent Collection db for: (AN/&…Cart] Searchi'ng US Patent Col[ection... Results of Search in US Patent Col]ection db for: (AN/&…Cart] Searchz`ng US Patent Collection. .. Results of Search in US Patent Col}ection db for: (AN/&…Document 23-2 Filed 06/29/2007 Page 1 of 17 DX 30 Patent l@a=sese€eacda®®¢dl§§lh»{("tamtanhemi®$i)? External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Boehringer Ingelheim
McKesson
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.